Clinical trial
Alfuzosin Versus Placebo in Acute Urinary Retention
NCT00453908 · Sanofi, Industry · Terminated
Key facts
| NCT number | NCT00453908 |
|---|---|
| Title | Alfuzosin Versus Placebo in Acute Urinary Retention |
| Official title | Does Alfuzosin OD vs. Placebo in Male Patients Facilitate Spontaneous Voiding During Clean Intermittent Self-Catheterization Following Acute Urinary Retention? |
| Acronym | ALF-RIK |
| Lead sponsor | Sanofi, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Urinary Retention |
| Intervention type | Drug |
| Interventions | Alfuzosin |
| Enrollment | 160 |
| Start date | May 1, 2004 |
| First posted | Mar 29, 2007 |
| Last update posted | Aug 20, 2007 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: